- $279.34m
- $251.25m
- 16
- 22
- 43
- 16
Annual income statement for Cybin, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0.864 | 0 | 0 |
| Cost of Revenue | ||||
| Gross Profit | 0 | 0.2 | 0 | — |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 0.81 | 32.2 | 63.8 | 51.5 |
| Operating Profit | -0.81 | -31.3 | -63.8 | -51.5 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0.81 | -32.2 | -67.6 | -47.5 |
| Net Income After Taxes | -0.81 | -32.2 | -67.6 | -47.5 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.81 | -32.2 | -67.6 | -47.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.81 | -32.2 | -67.6 | -47.5 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.016 | -0.314 | -0.404 | -0.256 |
| Dividends per Share |